FACTANKER
Altamira Therapeutics Ltd.: xbrl:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset
Value
{"amount": -526541, "currency": "USD"}
Period
2024-01-01 – 2024-12-31
Status
current
Entity
Altamira Therapeutics Ltd.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-25-037199
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER,
https://factanker.com/fact/11ca3b9c-bdde-417d-86ec-d41dd98b66a0
History
no predecessors — first report